After 12 weeks of nebulized NAC, patients’ mean phlegm scores, as measured by the COPD assessment test, significantly decreased from 3.47 at baseline to 2.62. N-acetylcysteine (NAC) nebulizer ...

Chronic obstructive pulmonary disease is one of the world’s leading causes of death - more than 300 million live with the ...

According to Research by SNS Insider, Nebulizer Market Growth is Driven by Rising Prevalence of Chronic Respiratory Diseases and Technological Advancements.Austin, Oct. 18, 2024 (GLOBE NEWSWIRE) -- ...

Inhalers used to treat symptoms of respiratory disease can be potent sources of greenhouse gases. Drugmakers are planning to ...

Steroid tablets are associated with significant adverse side effects. Short-term use risks sleep disturbance, reflux, ...

The global airway disease treatment market is projected to experience significant growth over the next decade, with revenue ...

The Asthma Society of Ireland has warned that over-use of steroid medication may cause more harm than good. A study has shown ...

The annual meeting of the American College of Chest Physicians was held this year from Oct. 6 to 9 in Boston, hosting participants from around the world, including specialists and heath care ...

Two posters presented at the CHEST 2024 annual meeting showed that mepolizumab significantly reduces exacerbations in ...

Patients with asthma and COPD routinely switch from pressurized metered-dose inhalers to dry powder inhalers and vice versa.

People who suffer from asthma in Ireland have significant levels of steroid use, including children, a new survey reveals ...

The American Lung Association Research Institute has announced a $22 million investment in 2024 to fund 139 research grants ...